Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma

Conditions: Multiple Myeloma Interventions: Drug: Iberdomide; Drug: Isatuximab; Drug: Dexamethasone Sponsors: University of Heidelberg Medical Center; KKS Netzwerk; Wuerzburg University Hospital; Sanofi; Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials